Tsukasa Morii
Overview
Explore the profile of Tsukasa Morii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toyama H, Takahashi K, Shimizu T, Otaka I, Abe S, Kato S, et al.
Endocr J
. 2024 Feb;
71(4):409-416.
PMID: 38346770
A 67-year-old man with type 1 diabetes, Cronkhite-Canada syndrome, and membranous nephropathy who received insulin therapy was admitted to our hospital with right hemiplegia and dysarthria. Brain magnetic resonance imaging...
2.
Kato S, Otaka I, Toyama H, Kusumi R, Takahashi K, Nara M, et al.
Diabetol Int
. 2022 Sep;
13(4):698-703.
PMID: 36117927
Although the measurement of hemoglobin A1c (HbA1c) using high-performance liquid chromatography (HPLC) is routinely used to estimate average blood glucose levels, it may not be accurately measured for various reasons,...
3.
Takahashi Y, Shimizu T, Kato S, Nara M, Suganuma Y, Sato T, et al.
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34071003
Superoxide dismutase (SOD) is a major antioxidant enzyme for superoxide removal, and cytoplasmic SOD (SOD1) is expressed as a predominant isoform in all cells. We previously reported that renal SOD1...
4.
Otomo H, Nara M, Kato S, Shimizu T, Suganuma Y, Sato T, et al.
Metabolism
. 2020 Oct;
113:154405.
PMID: 33069809
Aims: The crosstalk between sodium-glucose cotransporter 2 (SGLT2) inhibition and a membrane-associated endocytic receptor megalin function involved in renal proximal tubular protein overload in progressive diabetic nephropathy (DN) is uncertain....
5.
Suganuma Y, Shimizu T, Sato T, Morii T, Fujita H, Sassa M, et al.
J Diabetes Investig
. 2019 Jul;
11(2):389-399.
PMID: 31301103
Aims/introduction: Pharmacological levels of glucagon-like peptide-1 (GLP-1) can decelerate gastric emptying (GE) and reduce postprandial glucose levels. Most previous studies have used liquid meals to evaluate GE. We evaluated the...
6.
Hoizumi M, Sato T, Shimizu T, Kato S, Tsukiyama K, Narita T, et al.
Biochem Biophys Res Commun
. 2019 Apr;
513(4):974-982.
PMID: 31003779
Aims/introduction: Caloric restriction (CR) promotes longevity and exerts anti-aging effects by increasing Sirtuin production and activation. Gastric inhibitory polypeptide (GIP), a gastrointestinal peptide hormone, exerts various effects on pancreatic β-cells...
7.
Fukuoka Y, Narita T, Fujita H, Morii T, Sato T, Sassa M, et al.
J Diabetes Investig
. 2018 Aug;
10(2):322-330.
PMID: 30098231
Aims/introduction: To investigate the prevalence of sarcopenia, its related factors and indicators of physical evaluation in elderly diabetes patients. Materials And Methods: This was a cross-sectional observation study. A total...
8.
Kondo M, Tanabe K, Amo-Shiinoki K, Hatanaka M, Morii T, Takahashi H, et al.
Diabetologia
. 2018 Jul;
61(10):2189-2201.
PMID: 30054673
Aims/hypothesis: Loss of functional beta cells results in a gradual progression of insulin insufficiency in Wolfram syndrome caused by recessive WFS1 mutations. However, beta cell dysfunction in Wolfram syndrome has...
9.
Takashima S, Fujita H, Fujishima H, Shimizu T, Sato T, Morii T, et al.
Kidney Int
. 2016 Aug;
90(4):783-96.
PMID: 27475229
The role of stromal cell-derived factor-1 (SDF-1) in the pathogenesis of diabetic nephropathy and its modification by dipeptidyl peptidase-4 (DPP-4) inhibition are uncertain. Therefore, we studied this independent of glucagon-like...
10.
Campbell J, Ussher J, Mulvihill E, Kolic J, Baggio L, Cao X, et al.
Nat Med
. 2015 Dec;
22(1):84-90.
PMID: 26642437
The glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor transduce nutrient-stimulated signals to control beta cell function. Although the GLP-1 receptor (GLP-1R) is a validated drug target...